South Korea · Delayed Price · Currency is KRW Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 230.58 billion. The enterprise value is 363.27 billion.
| Market Cap | 230.58B |
| Enterprise Value | 363.27B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
KRX:009290 has 39.28 million shares outstanding. The number of shares has decreased by -1.13% in one year.
| Current Share Class | 39.28M |
| Shares Outstanding | 39.28M |
| Shares Change (YoY) | -1.13% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 12.95% |
| Owned by Institutions (%) | 25.65% |
| Float | 32.15M |
Valuation Ratios
The trailing PE ratio is 8.55.
| PE Ratio | 8.55 |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.88, with an EV/FCF ratio of -62.15.
| EV / Earnings | 13.35 |
| EV / Sales | 0.22 |
| EV / EBITDA | 12.88 |
| EV / EBIT | 29.87 |
| EV / FCF | -62.15 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.53 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 9.03 |
| Debt / FCF | -49.32 |
| Interest Coverage | 1.45 |
Financial Efficiency
Return on equity (ROE) is 4.61% and return on invested capital (ROIC) is 1.11%.
| Return on Equity (ROE) | 4.61% |
| Return on Assets (ROA) | 0.86% |
| Return on Invested Capital (ROIC) | 1.11% |
| Return on Capital Employed (ROCE) | 2.22% |
| Revenue Per Employee | 1.59B |
| Profits Per Employee | 26.65M |
| Employee Count | 1,021 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 6.51 |
Taxes
In the past 12 months, KRX:009290 has paid 9.96 billion in taxes.
| Income Tax | 9.96B |
| Effective Tax Rate | 26.07% |
Stock Price Statistics
The stock price has increased by +7.89% in the last 52 weeks. The beta is 0.28, so KRX:009290's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +7.89% |
| 50-Day Moving Average | 5,940.20 |
| 200-Day Moving Average | 5,746.15 |
| Relative Strength Index (RSI) | 51.41 |
| Average Volume (20 Days) | 270,598 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.62 trillion and earned 27.21 billion in profits. Earnings per share was 686.22.
| Revenue | 1.62T |
| Gross Profit | 281.00B |
| Operating Income | 15.88B |
| Pretax Income | 38.21B |
| Net Income | 27.21B |
| EBITDA | 31.91B |
| EBIT | 15.88B |
| Earnings Per Share (EPS) | 686.22 |
Balance Sheet
The company has 194.59 billion in cash and 288.27 billion in debt, giving a net cash position of -93.68 billion or -2,384.99 per share.
| Cash & Cash Equivalents | 194.59B |
| Total Debt | 288.27B |
| Net Cash | -93.68B |
| Net Cash Per Share | -2,384.99 |
| Equity (Book Value) | 620.00B |
| Book Value Per Share | 14,790.87 |
| Working Capital | 246.64B |
Cash Flow
In the last 12 months, operating cash flow was 60.03 billion and capital expenditures -65.87 billion, giving a free cash flow of -5.84 billion.
| Operating Cash Flow | 60.03B |
| Capital Expenditures | -65.87B |
| Free Cash Flow | -5.84B |
| FCF Per Share | -148.79 |
Margins
Gross margin is 17.36%, with operating and profit margins of 0.98% and 1.68%.
| Gross Margin | 17.36% |
| Operating Margin | 0.98% |
| Pretax Margin | 2.36% |
| Profit Margin | 1.68% |
| EBITDA Margin | 1.97% |
| EBIT Margin | 0.98% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.73%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.43% |
| Buyback Yield | 1.13% |
| Shareholder Yield | 2.86% |
| Earnings Yield | 11.80% |
| FCF Yield | -2.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
| Last Split Date | Apr 26, 1999 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.53 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.53 |
| Piotroski F-Score | 5 |